Alzamend Neuro Inc (NASDAQ: ALZN) on November 20, 2023, started off the session at the price of $1.71, plunging -17.75% from the previous trading day. During the day, the shares moved up to $1.92 and dropped to $1.14 before settling in for the closing price of $1.69. Within the past 52 weeks, ALZN’s price has moved between $1.32 and $19.80.
The company achieved an average annual earnings per share of -13.33%. With a float of $3.26 million, this company’s outstanding shares have now reached $6.46 million.
Let’s determine the extent of company efficiency that accounts for 4 employees.
Alzamend Neuro Inc (ALZN) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Alzamend Neuro Inc is 49.55%, while institutional ownership is 6.48%. The most recent insider transaction that took place on Sep 26, was worth 10,234. In this transaction Chief Financial Officer of this company bought 53,000 shares at a rate of $0.19, taking the stock ownership to the 81,000 shares. Before that another transaction happened on May 24, when Company’s 10% Owner bought 18,000 for $0.59, making the entire transaction worth $10,705. This insider now owns 383,000 shares in total.
Alzamend Neuro Inc (ALZN) Earnings and Forecasts
As on 7/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.6 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.52) by -$0.08. This company achieved a return on equity of -181.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -13.33% per share during the next fiscal year.
Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators
Alzamend Neuro Inc (ALZN) is currently performing well based on its current performance indicators. A quick ratio of 0.88 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.36, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.62 in one year’s time.
Technical Analysis of Alzamend Neuro Inc (ALZN)
Looking closely at Alzamend Neuro Inc (NASDAQ: ALZN), its last 5-days average volume was 0.95 million, which is a jump from its year-to-date volume of 36100.0. As of the previous 9 days, the stock’s Stochastic %D was 43.57%. Additionally, its Average True Range was 0.28.
During the past 100 days, Alzamend Neuro Inc’s (ALZN) raw stochastic average was set at 3.52%, which indicates a significant decrease from 29.07% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.50% in the past 14 days, which was higher than the 102.14% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.7038, while its 200-day Moving Average is $6.3292. However, in the short run, Alzamend Neuro Inc’s stock first resistance to watch stands at $1.8267. Second resistance stands at $2.2633. The third major resistance level sits at $2.6067. If the price goes on to break the first support level at $1.0467, it is likely to go to the next support level at $0.7033. Should the price break the second support level, the third support level stands at $0.2667.
Alzamend Neuro Inc (NASDAQ: ALZN) Key Stats
Market capitalization of the company is 8.99 million based on 6,466K outstanding shares. Right now, sales total 0 K and income totals -14,880 K. The company made 0 K in profit during its latest quarter, and -3,530 K in sales during its previous quarter.